Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventive IVIG Therapy for Congenital Heart Block (The PITCH Study)

NCT00460928 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00460928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventive IVIG Therapy for Congenital Heart Block (The PITCH Study)
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2007
Completion date
June 30, 2009
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoantibody-associated heart block, congenital heart block, neonatal lupus